Cargando…

Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles

With the development of nanomedicine, a mass of nanocarriers have been exploited and utilized for targeted drug delivery, including liposomes, polymers, nanoparticles, viruses, and stem cells. Due to huge surface bearing capacity and flexible genetic engineering property, filamentous bacteriophage a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Zhigang, Sun, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241185/
https://www.ncbi.nlm.nih.gov/pubmed/29191048
http://dx.doi.org/10.1080/10717544.2017.1410259
_version_ 1783715360231391232
author Ju, Zhigang
Sun, Wei
author_facet Ju, Zhigang
Sun, Wei
author_sort Ju, Zhigang
collection PubMed
description With the development of nanomedicine, a mass of nanocarriers have been exploited and utilized for targeted drug delivery, including liposomes, polymers, nanoparticles, viruses, and stem cells. Due to huge surface bearing capacity and flexible genetic engineering property, filamentous bacteriophage and phage-mimetic nanoparticles are attracting more and more attentions. As a rod-like bio-nanofiber without tropism to mammalian cells, filamentous phage can be easily loaded with drugs and directly delivered to the lesion location. In particular, chemical drugs can be conjugated on phage surface by chemical modification, and gene drugs can also be inserted into the genome of phage by recombinant DNA technology. Meanwhile, specific peptides/proteins displayed on the phage surface are able to conjugate with nanoparticles which will endow them specific-targeting and huge drug-loading capacity. Additionally, phage peptides/proteins can directly self-assemble into phage-mimetic nanoparticles which may be applied for self-navigating drug delivery nanovehicles. In this review, we summarize the production of phage particles, the identification of targeting peptides, and the recent applications of filamentous bacteriophages as well as their protein/peptide for targeting drug delivery in vitro and in vivo. The improvement of our understanding of filamentous bacteriophage and phage-mimetic nanoparticles will supply new tools for biotechnological approaches.
format Online
Article
Text
id pubmed-8241185
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-82411852021-07-08 Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles Ju, Zhigang Sun, Wei Drug Deliv Review Article With the development of nanomedicine, a mass of nanocarriers have been exploited and utilized for targeted drug delivery, including liposomes, polymers, nanoparticles, viruses, and stem cells. Due to huge surface bearing capacity and flexible genetic engineering property, filamentous bacteriophage and phage-mimetic nanoparticles are attracting more and more attentions. As a rod-like bio-nanofiber without tropism to mammalian cells, filamentous phage can be easily loaded with drugs and directly delivered to the lesion location. In particular, chemical drugs can be conjugated on phage surface by chemical modification, and gene drugs can also be inserted into the genome of phage by recombinant DNA technology. Meanwhile, specific peptides/proteins displayed on the phage surface are able to conjugate with nanoparticles which will endow them specific-targeting and huge drug-loading capacity. Additionally, phage peptides/proteins can directly self-assemble into phage-mimetic nanoparticles which may be applied for self-navigating drug delivery nanovehicles. In this review, we summarize the production of phage particles, the identification of targeting peptides, and the recent applications of filamentous bacteriophages as well as their protein/peptide for targeting drug delivery in vitro and in vivo. The improvement of our understanding of filamentous bacteriophage and phage-mimetic nanoparticles will supply new tools for biotechnological approaches. Taylor & Francis 2017-12-01 /pmc/articles/PMC8241185/ /pubmed/29191048 http://dx.doi.org/10.1080/10717544.2017.1410259 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Ju, Zhigang
Sun, Wei
Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles
title Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles
title_full Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles
title_fullStr Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles
title_full_unstemmed Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles
title_short Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles
title_sort drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241185/
https://www.ncbi.nlm.nih.gov/pubmed/29191048
http://dx.doi.org/10.1080/10717544.2017.1410259
work_keys_str_mv AT juzhigang drugdeliveryvectorsbasedonfilamentousbacteriophagesandphagemimeticnanoparticles
AT sunwei drugdeliveryvectorsbasedonfilamentousbacteriophagesandphagemimeticnanoparticles